Top Ranked Value Stocks to Buy for September 12th

DAC AER PFSI COOP

Here are four stocks with buy rank and strong value characteristics for investors to consider today, September 12th:

Mr. Cooper Group Inc. (COOP - Free Report) : This mortgage loan originator and servicer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 41.9% over the last 60 days.

Mr. Cooper has a price-to-earnings ratio (P/E) of 4.40 compared with 8.50 for the industry. The company possesses a Value Score of A.

MR. COOPER GROUP INC PE Ratio (TTM)

AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 15.4% over the last 60 days.

Aercap Holdings N.V. Price and Consensus

AerCap has a price-to-earnings ratio (P/E) of 7.12 compared with 13.10 for the industry. The company possesses a Value Score of A.

Aercap Holdings N.V. PE Ratio (TTM)

Danaos Corporation (DAC - Free Report) : This owner of containerships has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 7.9% over the last 60 days.

Danaos Corporation Price and Consensus

Danaos has a price-to-earnings ratio (P/E) of 0.82 compared with 7.50 for the industry. The company possesses a Value Score of A.

Danaos Corporation PE Ratio (TTM)

PennyMac Financial Services, Inc. (PFSI - Free Report) : This specialty financial services company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 22% over the last 60 days.

PennyMac Financial Services, Inc. Price and Consensus

PennyMac Financial Services has a price-to-earnings ratio (P/E) of 8.59 compared with 40.10 for the industry. The company possesses a Value Score of B.

PennyMac Financial Services, Inc. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>